Sort
64,565 grants matching “drug discovery”
Development of Protein Degraders Targeting EZH2 Non-enzymatic Functions in Prostate Cancer
$643,148Jindan Yu · Emory University · R01 · FY2025 · CA
Reconfigurable microfluidic assay platform for molecular library screening
$643,058Peter Russell Charles Gascoyne · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · EB
Small-molecule STAT3 degraders
$643,055Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Identification of REV-ERB inverse agonists for cancer immunotherapy
$643,014Laura A Solt · Scripps Florida · R01 · FY2020 · CA
PRETARGETING WITH ANTI-CEA MABS FOR THERAPY
$642,945Paul Yazaki · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA
Broad-spectrum therapeutics against SARS-CoV-2 3CL protease
$642,901Raymond F. Schinazi · Emory University · R01 · FY2025 · AI
Accelerating the Discovery of Antifungal Peptides with OBOC Combinatorial Technology.
$642,775Angela Gelli · University Of California At Davis · R56 · FY2025 · AI
Impact of RNAi and unisexual reproduction on Cryptococcus evolution, drug resistance, and pathogenesis
$642,774Joseph Heitman · Duke University · R01 · FY2021 · AI
Research Infrastructure Core
$642,765Timothy Moore · Florida Agricultural And Mechanical Univ · U54 · FY2021 · MD
Impact of RNAi and unisexual reproduction on Cryptococcus evolution, drug resistance, and pathogenesis
$642,748Joseph Heitman · Duke University · R01 · FY2022 · AI
Development of screens for drugs in alcohol dependence
$642,748John M Littleton · University Of Kentucky · R01 · FY2006 · AA
Impact of RNAi and unisexual reproduction on Cryptococcus evolution, drug resistance, and pathogenesis
$642,695Joseph Heitman · Duke University · R01 · FY2023 · AI
Impact of RNAi and unisexual reproduction on Cryptococcus evolution, drug resistance, and pathogenesis
$642,695Joseph Heitman · Duke University · R01 · FY2025 · AI
Impact of RNAi and unisexual reproduction on Cryptococcus evolution, drug resistance, and pathogenesis
$642,695Joseph Heitman · Duke University · R01 · FY2024 · AI
Drug Abuse: Discovering Ligands for Pertinent GPCRs
$642,616Marc G. Caron · Duke University · P30 · FY2016 · DA
Defining an Obesity QTL on Chromosome 3q
$642,570Xiaofeng Zhu · Case Western Reserve University · R01 · FY2007 · HL
Roles of Noncoding RNA in Bone Regeneration
$642,531Jake Jinkun Chen · Tufts University Boston · R01 · FY2021 · DE
Fluorescence System for Sensing Biospecific Interactions
$642,455Bioelectrospec, Inc. · R44 · FY2002 · RR
E7 TCR-T cell therapy for HPV-associated cancers
$642,086Christian Hinrichs · Rutgers Biomedical And Health Sciences · U01 · FY2024 · CA
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations
$642,048Keoki Williams · Henry Ford Health System · R01 · FY2017 · DK
Drug Abuse: Discovering Ligands for Pertinent GPCRs
$642,037Marc G. Caron · Duke University · P30 · FY2015 · DA
Molecular characterization of myeloma and related asymptomatic precursor states
$642,027Elizabeth E Brown · University Of Alabama At Birmingham · R01 · FY2014 · CA
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
$642,003Thomas E Ferrin · University Of California, San Francisco · R01 · FY2019 · GM
^Identification of novel secondary metabolites produced by symbiotic Proteobacte
$641,924Jon Clardy · University Of Wisconsin-Madison · U19 · FY2014 · AI
Inflammation and cancer treatment
$641,901David Wink · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA